RxDoctor Payments DataLook up a doctor →

John Staheli, MD

Sleep Medicine · Provo, UTNPI 1275591620

Payments from drug & device makers

$9,442in general payments, 2019–2025

Across 589 payments — averaging $16.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Harmony Biosciences LLC$1K
  • AbbVie$874
  • Jazz Pharmaceuticals Inc.$835
  • Lilly USA, LLC$833
  • Axsome Therapeutics, Inc.$681
  • AstraZeneca$604
  • plus $5K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Harmony Biosciences LLC58$1,023
AbbVie(2 entities)47$874
Jazz Pharmaceuticals Inc.31$835
Lilly USA, LLC77$833
Axsome Therapeutics, Inc.36$681
AstraZeneca40$604
Avadel CNS Pharmaceuticals, LLC32$471
Novo Nordisk30$442
Amgen20$322
Sanofi-aventis U.S. LLC19$304
Novartis15$268
Boehringer Ingelheim15$243
Astellas Pharma US Inc15$241
Bayer14$229
Pfizer23$197
Philips North America LLC4$150
Sanofi Pasteur Inc.8$149
GSK8$125
Johnson & Johnson13$123
Amarin Pharma, Inc.7$113
Fisher & Paykel Healthcare Inc6$89
Baxter Healthcare4$84
Inspire Medical Systems, Inc.4$78
Actelion Pharmaceuticals US, Inc.6$71
Merck5$71
Avanir Pharmaceuticals, Inc.4$57
Idorsia Pharmaceuticals US Inc3$45
Resmed Corp3$44
Abbott2$40
Boston Scientific2$38
Arbor Pharmaceuticals, Inc.3$36
Sumitomo Pharma America, Inc.2$34
Radius Health, Inc.2$33
Sunovion Pharmaceuticals Inc.3$33
3b Medical, Inc.2$32
Neurocrine Biosciences, Inc.2$31
Edwards Lifesciences1$29
Madrigal Pharmaceuticals1$26
Medtronic1$26
Shire North American Group Inc1$22
Mylan Specialty L.p.1$21
Dexcom, Inc.1$19
Biogen1$19
Lundbeck LLC1$17
Aimmune Therapeutics, Inc.1$17
Mannkind Corporation1$17
GE HealthCare1$16
BD1$16
Averitas Pharma Inc.1$15
Almatica Pharma LLC1$15
Kowa Pharmaceuticals America, Inc.1$15
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$14
Phathom Pharmaceuticals, Inc.1$14
Grifols USA, LLC1$14
Neurelis, Inc.1$12
E.r. Squibb & Sons, L.L.C.1$12
Eisai Inc.1$12
Biohaven Pharmaceuticals, Inc.1$11
Daiichi Sankyo Inc.1$11
Itamar Medical Inc1$10

How this compares

$9,442 in reported general payments places this provider in the 70th percentile of 20 sleep medicine providers in Utah.

See all sleep medicine providers in Utah →

Medicare billing

Part B allowed, 2024
$297,848
Medicare patients
743
Services billed
2,466

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other sleep medicine in Provo

See the full list for Utah →

Where these figures come from

Is this you, or does something look wrong? →